CClinicalTrials.gg
CompletedNCT05112809Updated Dec 30, 2025Results posted

Noninvasive Cochlear Stimulation System

An interventional study of Cochlear Stimulation System (CSS) in Healthy, sponsored by Mayo Clinic. Completed at 1 site in United States. Open to participants aged 21 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-30.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Non-randomized
Ages
21 Years to 75 Years
Sex
All
01

Study summary

The purpose of this research is to develop a portable wearable hardware headset using a computer-based software that can establish the optimal stimulation parameters appropriate for medical and consumer environments for individuals with hearing impaired and normal hearing individuals.

02

Conditions studied

  • Healthy

Keywords

  • Normal hearing
03

In context

Lead sponsor

Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.

Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

- Employee of Mayo Clinic.

Exclusion criteria

Exclusion Criteria:

  • Pregnant.
  • Cochlear implants.
  • History of fluctuating sensorineural hearing loss.
  • Skin diseases of the head.
  • History of acute paroxysmal tachycardia.
  • History of trigeminal neuralgia.
  • Recent of paralysis of the facial nerve.
  • Recent cerebrovascular stroke.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
68 participants (actual)

Study arms

  • Experimental
    Normal hearing subjects

    Subjects with normal hearing will have a standard hearing test utilizing the cochlear stimulation system.

    Device: Cochlear Stimulation System (CSS)

  • Experimental
    Bilateral hearing impaired

    Subjects with bilateral hearing impairment will have a standard hearing test utilizing the cochlear stimulation system.

    Device: Cochlear Stimulation System (CSS)

  • Experimental
    Asymmetrical hearing-impaired

    Subjects with asymmetrical hearing-impairment will have a standard hearing test utilizing the cochlear stimulation system.

    Device: Cochlear Stimulation System (CSS)

Interventions

  • DeviceCochlear Stimulation System (CSS)

    Cochlear stimulation with surround sound and noise cancellation

06

What researchers measure

Primary outcomes

  1. Mean Change in Electric Current Subjects Indicated They Could Hear a Tone at Certain Frequencies

    Evaluated by increasing the amplitude of the current input until the subject could hear a tone at 250 Hz, 500 Hz, 1,000 Hz, 2,000 Hz, 4,000 Hz, 8,000 Hz, 10,000 Hz, 12,500 Hz and 16,000 Hz. The mean electric current is reported in Milliampere (mA).

    Time frame: Baseline, approximately 2 hours

  2. Speech Intelligibility in Quiet Environment

    Measured using the modified rhyme test (MRT) consisting of a set of 50 six-item wordlist. Each word list contains single syllable words with a consonant-vowel-consonant sound sequence. Subjects completed electrical word recognition testing in a quiet environment. Electrodes were placed at 3 unique locations (forehead, mastoid, neck) to measure how well speech could be delivered to the subject through the skin electrodes in a manner that would allow subjects to recognize words in a quiet environment. There were 2 experiments done for speech intelligibility. The first involved 20 subjects (outcome 2) and aimed to assess speech intelligibility performance in a basic, quiet environment without background noise. This phase focused on evaluating the fundamental hearing performance. Once it was established that speech intelligibility was satisfactory with electrical stimulation, we proceeded to test an additional 30 subjects in both quiet and noisy environments (outcome 3).

    Time frame: Baseline, approximately 2 hours

  3. Speech Intelligibility in Quiet and Noisy Environments

    Measured using the modified rhyme test (MRT) consisting of a set of 50 six-item wordlist. Each word list contains single syllable words with a consonant-vowel-consonant sound sequence. Subjects completed electrical word recognition testing in a quiet, then a noisy environment. Electrodes were placed at 3 unique locations (mastoid, wrist, back) to measure how well speech could be delivered to the subject through the skin electrodes in a manner that would allow subjects to recognize words in a quiet and noisy environment. There were 2 experiments done for speech intelligibility. The first involved 20 subjects (outcome2) and aimed to assess speech intelligibility performance in a basic, quiet environment without background noise. This phase focused on evaluating the fundamental hearing performance. Once it was established that speech intelligibility was satisfactory with electrical stimulation, we proceeded to test an additional 30 subjects in both quiet and noisy environments (outcome3)

    Time frame: Baseline; approximately 2 hours

07

Results

Posted Dec 30, 2025

Participant flow

Participant flow — Overall Study
MilestoneNormal Hearing SubjectsBilateral Hearing ImpairedAsymmetrical Hearing-impaired
Started5558
Completed5558
Not completed000

Outcome measures

PrimaryMean Change in Electric Current Subjects Indicated They Could Hear a Tone at Certain Frequencies

Evaluated by increasing the amplitude of the current input until the subject could hear a tone at 250 Hz, 500 Hz, 1,000 Hz, 2,000 Hz, 4,000 Hz, 8,000 Hz, 10,000 Hz, 12,500 Hz and 16,000 Hz. The mean electric current is reported in Milliampere (mA).

Time frame:
Baseline, approximately 2 hours
Reported as:
Mean · mA
Mean Change in Electric Current Subjects Indicated They Could Hear a Tone at Certain Frequencies
mANormal Hearing SubjectsBilateral Hearing ImpairedAsymmetrical Hearing-impaired
250 Hz2.16 ± 1.072.88 ± 1.442.88 ± 0.97
500 Hz1.86 ± 1.622.93 ± 1.422.40 ± 1.14
1,000 Hz1.09 ± 0.421.75 ± 0.531.70 ± 0.42
2,000 Hz1.29 ± 0.431.77 ± 0.811.71 ± 0.60
4,000 Hz1.56 ± 0.673.50 ± 2.351.84 ± 0.68
8,000 Hz1.71 ± 0.792.25 ± 1.063.00 ± 1.76
10,000 Hz1.97 ± 1.063.25 ± 1.063.96 ± 2.51
12,500 Hz2.29 ± 1.326.00 ± 3.463.67 ± 1.47
16,000 Hz2.94 ± 1.305.00 ± 0.004.21 ± 1.25
PrimarySpeech Intelligibility in Quiet Environment

Measured using the modified rhyme test (MRT) consisting of a set of 50 six-item wordlist. Each word list contains single syllable words with a consonant-vowel-consonant sound sequence. Subjects completed electrical word recognition testing in a quiet environment. Electrodes were placed at 3 unique locations (forehead, mastoid, neck) to measure how well speech could be delivered to the subject through the skin electrodes in a manner that would allow subjects to recognize words in a quiet environment. There were 2 experiments done for speech intelligibility. The first involved 20 subjects (outcome 2) and aimed to assess speech intelligibility performance in a basic, quiet environment without background noise. This phase focused on evaluating the fundamental hearing performance. Once it was established that speech intelligibility was satisfactory with electrical stimulation, we proceeded to test an additional 30 subjects in both quiet and noisy environments (outcome 3).

Time frame:
Baseline, approximately 2 hours
Reported as:
Mean · percentage of correct scores on MRT
Speech Intelligibility in Quiet Environment
percentage of correct scores on MRTNormal Hearing SubjectsBilateral Hearing ImpairedAsymmetrical Hearing-impaired
Forehead84.38 ± 14.9——
Mastoid94.06 ± 5.9——
Neck84.06 ± 11.6——
PrimarySpeech Intelligibility in Quiet and Noisy Environments

Measured using the modified rhyme test (MRT) consisting of a set of 50 six-item wordlist. Each word list contains single syllable words with a consonant-vowel-consonant sound sequence. Subjects completed electrical word recognition testing in a quiet, then a noisy environment. Electrodes were placed at 3 unique locations (mastoid, wrist, back) to measure how well speech could be delivered to the subject through the skin electrodes in a manner that would allow subjects to recognize words in a quiet and noisy environment. There were 2 experiments done for speech intelligibility. The first involved 20 subjects (outcome2) and aimed to assess speech intelligibility performance in a basic, quiet environment without background noise. This phase focused on evaluating the fundamental hearing performance. Once it was established that speech intelligibility was satisfactory with electrical stimulation, we proceeded to test an additional 30 subjects in both quiet and noisy environments (outcome3)

Time frame:
Baseline; approximately 2 hours
Reported as:
Mean · percentage of correct MRT scores
Speech Intelligibility in Quiet and Noisy Environments
percentage of correct MRT scoresNormal Hearing SubjectsBilateral Hearing ImpairedAsymmetrical Hearing-impaired
Mastoid-Quiet Environment93.86 ± 8.2——
Wrist-Quiet Environment93 ± 9.7——
Back-Quiet Environment93.83 ± 10.2——
Mastoid-Noisy Environment85.37 ± 11.7——
Wrist-Noisy Environment86 ± 12.7——
Back-Noisy Environment82.07 ± 12.5——

Adverse events

Collected over Adverse events were collected from the time of informed consent through study completion, approximately 2 hours.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Normal Hearing Subjects0/55 (0%)0/55 (0%)0/55 (0%)
Bilateral Hearing Impaired0/5 (0%)0/5 (0%)0/5 (0%)
Asymmetrical Hearing-impaired0/8 (0%)0/8 (0%)0/8 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Normal Hearing SubjectsBilateral Hearing ImpairedAsymmetrical Hearing-impairedTotal
Mean33.78 ± 9.3356.8 ± 11.3959 ± 13.4438.51 ± 13.84
Sex: Female, Male
Sex: Female, Male(Participants)Normal Hearing SubjectsBilateral Hearing ImpairedAsymmetrical Hearing-impairedTotal
Female313337
Male242531
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Normal Hearing SubjectsBilateral Hearing ImpairedAsymmetrical Hearing-impairedTotal
Hispanic or Latino112215
Not Hispanic or Latino372544
Unknown or Not Reported7119
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Normal Hearing SubjectsBilateral Hearing ImpairedAsymmetrical Hearing-impairedTotal
American Indian or Alaska Native0000
Asian6006
Native Hawaiian or Other Pacific Islander0000
Black or African American3104
White383849
More than one race0000
Unknown or Not Reported8109
Region of Enrollment
Region of Enrollment(participants)Normal Hearing SubjectsBilateral Hearing ImpairedAsymmetrical Hearing-impairedTotal
United States555868
08

Study locations

1 site
  • Mayo Clinic in Arizona
    Scottsdale, Arizona 85259, United States
09

References and documents

Publications

  • Kingsbury SE, Cevette MJ, Stepanek J, Pradhan GN. Investigating Speech Intelligibility Capabilities of Electrical Auditory Stimulation. Mil Med. 2026 Mar 1;191(3-4):e592-e600. doi: 10.1093/milmed/usaf430. PubMed 40899906 ↗

Study documents

  • Study protocol · Sep 12, 2024

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05112809
Lead sponsor
Mayo Clinic
Responsible party
Gaurav N. Pradhan (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Nov 9, 2021
Start date
Oct 6, 2023
Primary completion
Dec 20, 2024
Completion
Feb 6, 2025
Results posted
Dec 30, 2025
Last update
Dec 30, 2025

Study contacts

Michael J Cevette, PhD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion